The Enablers of Medical Impact in the Age of AI
Host: Christoph Bug, Vice President Global Medical, ³Ô¹Ï±¬ÁÏGuests: Andreas Gerloff, Director, Medical Excellence Operations, Daiichi Sankyo Europe
Michael Hamann, Executive Director, EMEAC Medical & Value Capabilities, Merck
Michael Hamann and Andreas Gerloff join Christoph Bug to examine key enablers of medical impact. Discover how Merck and Daiichi Sankyo Europe use AI to analyze MSL insights, personalize education, and measure relationship trust across an evolving healthcare ecosystem to improve patient outcomes.
